Evidence map›Paper›PMID 42487835›Full record

ReviewCureus2026

Purulent Pericardial Effusion: An Elusive Diagnosis.

Shaker Al-Nabulsi, Dania Hammadi, Ahmed Abozenah, Mohammed Abozenah, Julia Ladna

Abstract readReview
In one paragraph

Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shaker Al-NabulsiMedicine, Royal College of Surgeons in Ireland - Bahrain, Muharraq, BHR.
Dania HammadiMedicine, Royal College of Surgeons in Ireland - Bahrain, Muharraq, BHR.
Ahmed AbozenahInternal Medicine, Newgiza University, Cairo, EGY.
Mohammed AbozenahCardiovascular Medicine, University of Massachusetts Medical School - Baystate Medical Center, Springfield, USA.
Julia LadnaCardiovascular Medicine, Baystate Medical Center, Springfield, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purulent pericardial effusion (PPE) is a life-threatening infection of the pericardial space. While rare in the modern antimicrobial era, its rapidly progressive course, diagnostic challenges, and lack of management guidance make it a source of significant morbidity and mortality. Gram-positive bacteria are the most common causative organisms; however, polymicrobial and fungal infections are being increasingly recognized. Rapid diagnosis requires a high index of suspicion supported by clinical findings, pericardial fluid analysis, and imaging studies. Prompt drainage of the infected pericardial fluid along with early antimicrobial therapy remain the cornerstones of management, although gaps on optimal treatment duration, need for surgical intervention, and follow-up persist. This review aims to bridge some of these gaps by examining the current literature on purulent pericardial effusion, highlighting the epidemiology, microbiology, clinical manifestations, diagnostic challenges, management strategies, and both short-term and long-term outcomes of this deadly condition.

Indexed as

cardiac tamponadefungal pericarditispericardiocentesispolymicrobial infectionpurulent pericardial effusiontuberculous pericarditis

Identifiers

PMID42487835
PMCPMC13389797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.